IP Library › Assignment 041048/0299
Patent Assignment
Reel/Frame 041048/0299

Security Interest

Recorded: 2017-01-23 Pages: 14
Assignors
HIGHLAND THERAPEUTICS INC.
Executed: 2017-01-18
NORTH SOUND PHARMACEUTICALS, INC.
Executed: 2017-01-18
IRONSHORE PHARMACEUTICALS INC.
Executed: 2017-01-18
Assignee
U.S. BANK NATIONAL ASSOCIATION
ONE FEDERAL STREET, 3RD FLOOR, BOSTON, MASSACHUSETTS, 02110
Covered Properties (14)
Methods and Compositions for Treatment of Attention Deficit Disorder
Patent: 9,028,868 →
Application: 13/429,292 →
Publication: US 2012/0276017
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 8,927,010 →
Application: 14/230,053 →
Publication: US 2014/0212483
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 8,916,588 →
Application: 14/230,067 →
Publication: US 2014/0212461
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,119,809 →
Application: 14/255,529 →
Publication: US 2014/0227197
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,034,902 →
Application: 14/577,963 →
Publication: US 2015/0110868
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,023,389 →
Application: 14/589,839 →
Publication: US 2015/0125521
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,283,214 →
Application: 14/704,836 →
Publication: US 2015/0231125
Method of Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,603,808 →
Application: 14/710,453 →
Publication: US 2015/0238443
Methods of Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,603,809 →
Application: 14/716,777 →
Publication: US 2015/0313849
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,289,394 →
Application: 14/841,428 →
Publication: US 2015/0366816
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,498,447 →
Application: 15/069,734 →
Publication: US 2016/0193156
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Patent: 9,511,032 →
Application: 15/076,253 →
Publication: US 2016/0199312
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application: 15/359,202 →
Publication: US 2017/0071864
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application: 15/366,900 →
Publication: US 2017/0079937
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 29, 2012
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 029424/0359 →
Assignment of Assignor's Interest Oct 31, 2013
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 031552/0812 →
Master Development Agreement Oct 31, 2013
From: HIGHLAND THERAPEUTICS, INC.
To: PHARMAFORM
Reel/Frame 031609/0883 →
Assignment of Assignor's Interest Nov 15, 2013
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 031733/0639 →
Corrective Assignment to Correct Assignee/Assignor Names; Previously Recorded at Reel 031609 Frame 0883. Assignor(S) Hereby Confirms the Assignment. Feb 19, 2014
From: FORMULATION TECHNOLOGIES L.L.C. D/B/A PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032425/0435 →
Assignment of Assignor's Interest Apr 3, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0126 →
Assignment of Assignor's Interest Apr 3, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032611/0144 →
Assignment of Assignor's Interest Apr 3, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0128 →
Assignment of Assignor's Interest Apr 3, 2014
From: FORMULATION TECHNOLOGIES, L.L.C. D/B/A PHARR
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032611/0130 →
Assignment of Assignor's Interest Apr 3, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032611/0146 →
Assignment of Assignor's Interest Apr 3, 2014
From: FORMULATION TECHNOLOGIES, L.L.C. D/B/A PHARR
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032611/0137 →
Assignment of Assignor's Interest Apr 3, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0122 →
Assignment of Assignor's Interest Apr 3, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0124 →
Assignment of Assignor's Interest Apr 25, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032799/0978 →
Assignment of Assignor's Interest Apr 25, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032799/0931 →
Assignment of Assignor's Interest Apr 25, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032800/0028 →
Master Development Agreement May 8, 2014
From: FORMULATION TECHNOLOGIES L.L.C. D/B/A PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032845/0794 →
Assignment of Assignor's Interest Jan 7, 2015
From: FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
To: HIGHLAND THERAPEUTICS, INC.
Reel/Frame 034741/0625 →
Assignment of Assignor's Interest Jan 7, 2015
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034741/0294 →
Assignment of Assignor's Interest Jan 7, 2015
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC
Reel/Frame 034731/0809 →
Assignment of Assignor's Interest Jan 7, 2015
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034730/0474 →
Assignment of Assignor's Interest Jan 7, 2015
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
Reel/Frame 034730/0421 →
Assignment of Assignor's Interest Jan 7, 2015
From: FORMULATION TECHNOLOGIES LLC DBA PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 034729/0571 →
Assignment of Assignor's Interest Jan 7, 2015
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034654/0547 →
Assignment of Assignor's Interest Jan 7, 2015
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034652/0787 →